Zhejiang Taimei Medical Technology Co., Ltd. logo

Zhejiang Taimei Medical Technology Co., Ltd. (2576)

Market Closed
13 Aug, 08:00
HKEX HKEX
5. 50
HKD
0
0%
HKD
3.34B Market Cap
- P/E Ratio
- Div Yield
685,600 Volume
- Eps
5.5 HKD
Previous Close
Add Transaction
Day Range
5.36 5.55
Year Range
3.61 7.5
Want to track 2576 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

2576 closed today higher at 5.5 HKD, an increase of 0% from yesterday's close, completing a monthly increase of 1.8519% or 0.1 HKD. Over the past 12 months, 2576 stock gained 44.357%.
2576 is not paying dividends to its shareholders.
The last earnings report, released on Mar 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

2576 Chart

People also search for

Jinshang Bank Co., Ltd.
1.19 HKD
0%
Medlive Technology Co., Ltd.
7.93 HKD
-0.4394%
Nanhua Futures Co., Ltd.
6.38 HKD
-3.3333%
Health and Happiness (H&H) International Holdings Ltd.
15.41 HKD
-1.2179%
Luzhou Bank Co. Ltd.
2.23 HKD
0%

Zhejiang Taimei Medical Technology Co., Ltd. (2576) FAQ

What is the stock price today?

The current price is 5.50 HKD.

On which exchange is it traded?

Zhejiang Taimei Medical Technology Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 2576.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.34B.

Has Zhejiang Taimei Medical Technology Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Zhejiang Taimei Medical Technology Co., Ltd. Profile

Insurance Industry
Financials Sector
Mr. Zhao Lu CEO
HKEX Exchange
CNE100006M66 ISIN
China Country
783 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, is at the forefront of digital transformation in the biopharma industry within China. The company specializes in developing a comprehensive digital operation platform named TrialOS, aimed at enhancing cooperation across various segments of the pharmaceutical industry. This includes hospitals, pharmaceutical companies, regulatory authorities, patients, and other stakeholders. Zhejiang Taimei leverages big data technology and an array of software solutions to streamline clinical trials, regulatory compliance, patient management, and pharmaceutical marketing, thereby facilitating better decision-making and operational efficiencies across the biopharma ecosystem.

Products and Services

  • eCooperate - A clinical trial cooperation platform designed to optimize the management systems of clinical research operations, benefiting from the integration of big data for enhanced decision-making processes.
  • eArchives - This is a clinical trial master file system that provides a centralized repository for all essential documents related to clinical trials, ensuring compliance and facilitating audit-readiness.
  • eCollect - An electronic data capture system that enables the efficient collection and management of clinical trial data, improving the accuracy and reliability of research findings.
  • eCollege - A training management system dedicated to facilitating the education and qualification of clinical trial staff, ensuring they remain up-to-date with industry standards and regulatory requirements.
  • eQuality - An electronic quality audit system designed to streamline the quality assurance process for clinical trials, enhancing the integrity and compliance of research practices.
  • eBalance - An interactive web-based response system that manages randomization and trial supply management, ensuring trial integrity and reducing bias.
  • eVisit Patient Reported Outcomes - This solution improves patient engagement in clinical trials by facilitating easier data entry by patients themselves, which can lead to higher accuracy of trial data.
  • eTime - A project man-hour management system that enables efficient tracking and management of time expenditure across clinical trial projects, aiding in resource allocation and project planning.
  • eImage - A medical image reading system that supports the unbiased and accurate interpretation of medical images, integral to many clinical research studies.
  • Hospital Software Suite includes:
    • eTrial - A phase I ward management system tailored for the unique needs and complexities of early-phase clinical trials.
    • eSite - A clinical trial management system designed for GCP (Good Clinical Practice) sites, streamlining trial operations at the site level.
    • GCP-X - An intelligent clinical trial platform that incorporates advanced analytics and machine learning to enhance trial design and execution.
    • NomenCTMS - A management system for GCP sites that facilitates the efficient administration of clinical research projects.
    • eScreening - A management system for verifying subject information and preventing duplicate subject participation in trials.
    • Intelligent Investigator - A platform that empowers investigators to initiate, design, and manage their own clinical trials with greater autonomy and efficiency.
    • IIT-EDC - A data management platform focused on supporting investigator-initiated trials with robust data collection and analysis tools.
    • Investigator-Initiated Clinical Trial Management System - A comprehensive project management system for the streamlined execution of investigator-initiated trials.
  • Pharmacovigilance Software Solutions includes:
    • eSafety Global Pharmacovigilance System - A system that provides comprehensive tools for the international management of drug safety data.
    • eSafety - An intelligent information system for managing pharmacovigilance activities, designed to optimize the detection, assessment, understanding, and prevention of adverse effects.
    • SAE Manager - A safety data communication and management system tailored to the needs of clinical trials, ensuring timely and compliant adverse event reporting.
  • Marketing Software and Digital Innovation Solutions - Apart from its core clinical and pharmacovigilance systems, Zhejiang Taimei also offers a range of solutions to support the marketing efforts and digital transformation initiatives of pharmaceutical companies.

Contact Information

Address: No.9 Building
Phone: 86 573 82682386